De Berti Jacchia, with a team composed by the attorneys Marco Frazzica and Giuseppina Zoccali, supported in the due diligence by a group led by attorney Matteo Bilei, assisted Indutrade Group, in the negotiation of an agreement to acquire all participations in the Italian company SLT srl, www.sltsrl.com, with annual sales of approximately EUR 7.5 million (SEK 85 million).
SLT is a technical trading company offering testing and safety control devices for the medical technology and healthcare sectors. The company specializes in products for safety and performance verification of medical equipment and bioimaging, complemented with calibration services and training programs. Customers include OEM’s which produce medical equipment, global service providers and hospitals. SLT was founded in 1949, has 19 employees and is located in Milan, Italy.
The closing is expected to take place during Q3 2025. SLT will be included in Indutrade’s Business Area Life Science. The acquisition will be Indutrade’s fifth in 2025 and is expected to have a marginally positive impact on Indutrade’s earnings per share.
Listed on the Nasdaq in Stockholm, Sweden, Indutrade is an international group operating in the technology and industrial sectors that today consists of more than 200 companies in about 30 countries, mainly European. In a decentralized way, the group provides sustainable and profitable growth by developing and acquiring successful companies run by passionate entrepreneurs.